sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Interests in Mural Oncology plc
The Vanguard Group, Inc. has released an opening position disclosure under Rule 8.3 of the Irish Takeover Panel Act, 1997. The disclosure pertains to Mural Oncology plc and details various interests and short positions in relevant securities.
As of April 22, 2025, Vanguard controls 772,615 ordinary shares of Mural Oncology, amounting to 4.47%. No interests or positions in cash-settled derivatives or stock-settled derivatives are currently disclosed. The announcement includes a minor purchase transaction of 54 ordinary shares at 2.72 USD each.
No indemnity, option arrangements, or any significant agreements impacting the securities are reported. Moreover, Vanguard does not disclose any arrangements related to options or derivatives, nor are there attachments accompanying the form.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.